Gene expression signature predicts induction treatment response and clinical outcome in adult Colombian patients with acute lymphoblastic leukemia

被引：0
|
作者：
Cruz-Rodriguez, Nataly
Quijano, Sandra M.
Enciso, Leonardo J.
Combita, Alba L.
Zabaleta, Jovanny
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3121
引用
收藏
页数：4
相关论文
共 50 条
  • [31] In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome
    Maino, Elena
    Masciulli, Arianna
    Intermesoli, Tamara
    Spinelli, Orietta
    Pavoni, Chiara
    Tosi, Manuela
    Audisio, Ernesta
    Cattaneo, Chiara
    Fumagalli, Monica
    Cassibba, Vincenzo
    Mattei, Daniele
    Romani, Claudio
    Cortelezzi, Agostino
    Ciceri, Fabio
    Scattolin, Anna Maria
    Oldani, Elena
    Rambaldi, Alessandro
    Bassan, Renato
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S262 - S263
  • [32] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adult Patients
    Oriol, Albert
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 89 - 90
  • [33] CLINICAL, IMMUNOPHENOTYPIC, CYTOGENETIC AND MOLECULAR CHARACTERIZATION AND RESPONSE TO TREATMENT AT THE END OF INDUCTION IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
    Samudio, Angelica
    Figueredo, Diego
    Zelada, Ofelia
    Aponte, Sol
    Ayala-Lugo, Ana
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [34] P-glycoprotein expression in adult acute myeloid leukemia:: correlation with induction treatment outcome
    Tóthová, E
    Elbertová, A
    Fricová, M
    Kafková, A
    Hlebasková, A
    Svorcová, E
    Stecová, N
    Guman, T
    Raffac, S
    NEOPLASMA, 2001, 48 (05) : 393 - 397
  • [35] Clinical characteristics, treatment outcome, and prognosis of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    Faiz, M.
    Iqbal, Q. J.
    Naeem, M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 98 - 98
  • [36] Clinical outcome of the treatment of adult acute lymphoblastic leukemia (ALL) with the hyper-CVAD protocol.
    Marinakis, T
    Zomas, A
    Galanopoulos, AG
    Michalis, E
    Gortzolidis, G
    Tsourveloudis, L
    Savvidou, L
    Theodoropoulos, G
    Papadhimitriou, S
    Paterakis, G
    Grigoraki, V
    Georgiakaki, M
    Anagnostopoulos, NI
    BLOOD, 2005, 106 (11) : 226B - 226B
  • [37] The clinical outcome of adult Philadelphia (Ph)-positive acute lymphoblastic leukemia (ALL).
    Faderl, S
    Kantajian, HM
    Thomas, D
    Cortes, J
    Giles, F
    Estrov, Z
    BLOOD, 1998, 92 (10) : 225A - 225A
  • [38] In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile
    Sorich, Michael J.
    Pottier, Nicolas
    Pei, Deqing
    Yang, Wenjian
    Kager, Leo
    Stocco, Gabriele
    Cheng, Cheng
    Panetta, John C.
    Pui, Ching-Hon
    Relling, Mary V.
    Cheok, Meyling H.
    Evans, William E.
    PLOS MEDICINE, 2008, 5 (04): : 646 - 656
  • [39] Outcome of treatment in adult acute lymphoblastic leukemia in southern Brazil using a modified German Multicenter acute lymphoblastic leukemia protocol
    Fogliatto, L
    Bittencourt, H
    Nunes, AS
    Salenave, PR
    Silva, GS
    Daudt, LE
    Job, FM
    Bittencourt, R
    Onsten, T
    Silla, LMR
    ACTA HAEMATOLOGICA, 2002, 107 (04) : 203 - 207
  • [40] Reduction in WT1 Gene Expression During Early Treatment Predicts the Outcome in Patients With Acute Myeloid Leukemia
    Andersson, Charlotta
    Li, Xingru
    Lorenz, Fryderyk
    Golovleva, Irina
    Wahlin, Anders
    Li, Aihong
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (04) : 225 - 233
12345